Data for ST003049   

(Analysis AN005000): Average values per metabolite and experimental factor (Units:normalized AUC)

Metabolite structureAll dataF1F2
11-HDoHE
14.15 17.25
11-HETE
14.72 17.86
12-HEPE
15.02 20.80
12-HETE / 8-HETE
20.79 25.37
12-HETrE
14.61 16.97
12-HHTrE
14.63 17.60
13,14-dihydro-15-keto-PGE2
14.34 16.02
13,14-dihydro-15-keto-PGF2a
14.70 15.42
13-,16- and 17-HDoHE
14.28 15.65
14-HDoHE and 10-HDoHE
17.29 22.60
15-HETE
14.79 18.65
9- and 13-HODE_9(10)- and 12(13)-EPOME
17.32 19.40
9-HpODE
15.29 15.29
Deoxycholic Acid
20.12 20.51
Hepoxilin B3
14.57 18.34
HHTrE / isoform I
14.92 17.03
HHTrE / isoform II
14.62 17.97
HpODE / isoform I
16.06 16.18
LPC (0:0/16:0)
23.01 21.23
LPC (0:0/18:1)
20.78 19.52
LPC (0:0/18:2)
22.46 21.60
LPC (0:0/20:4)
21.40 21.05
LPC (0:0/22:6)
18.66 17.91
LPC (16:0/0:0)
25.45 23.99
LPC (18:1/0:0)
23.14 21.07
LPC (18:2/0:0)
24.07 21.95
LPC (20:4/0:0)
21.88 20.77
LPC (22:6/0:0)
19.96 18.70
LPE (0:0/16:0)
19.00 18.99
LPE (0:0/18:1)
19.88 19.85
LPE (0:0/18:2)
20.98 20.41
LPE (0:0/20:4)
23.45 23.91
LPE (0:0/20:5)
19.10 19.26
LPE (0:0/22:6)
20.82 20.74
LPE (16:0/0:0)
21.62 21.62
LPE (18:1/0:0)
21.32 21.01
LPE (18:2/0:0)
21.87 19.23
LPE (20:4/0:0)
21.52 20.54
LPE (22:6/0:0)
20.39 18.86
PGE2
14.60 19.16
PGF2a
14.55 14.95
Sphingosine-1-phosphate
20.44 22.61
TXB2
14.40 17.30

Factors:

F1Treatment:Control
F2Treatment:Platelet activation
  logo